This solidifies Attridge’s position as a successful South African business leader and prominent JSE investor.
Aspen Pharmacare
-
-
This strengthens Stephen Saad’s position as one of South Africa’s wealthiest individuals.
-
This follows a gain of $32.2 million recorded between April 23 and May 1, when his stake increased from $654.18 million to …
- Hot NewsLatest NewsSouthern Africa
South African tycoon Gus Attridge rakes in $6.2 million from Aspen shares
This follows a $12 million gain recorded between April 23 and May 3, when his stake rose from R4.07 billion ($219.65 million) …
-
Attridge, Aspen’s group chief advisor, and a JSE heavyweight, holds a 4.3-percent stake in the pharmaceutical company, amounting to 19,033,829 ordinary shares.
- Hot News
South African billionaire Stephen Saad’s Aspen to boost global supply of obesity medication
Aspen, Africa’s largest drugmaker, is actively exploring ways to ramp up the availability of these in-demand treatments worldwide.
-
The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake …
-
This rise in Saad’s stake underscores his pivotal role in South Africa’s business landscape, placing him among the top investors on the …
-
Aspen anticipates a robust second half of 2024, supported by the launch of sterile manufacturing contracts and continued growth in its active …
- Hot News
South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).